Laurence Reid

Insider Reports History

Location
300 Third Street, Cambridge, MA
Signature
/s/ Matthew L. Wein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laurence Reid:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Metagenomi, Inc. Director Stock Option (Right to Buy) 42K Sep 2, 2025 Direct
KalVista Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 17K Nov 23, 2024 Direct
Decibel Therapeutics, Inc. President and Chief Executive Officer, Director Common Stock 0 $5.03 Sep 25, 2023 Direct
Decibel Therapeutics, Inc. President and Chief Executive Officer, Director Stock Option (right to buy) 0 Sep 25, 2023 Direct

Insider Reports Filed by Laurence Reid

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MGX Metagenomi, Inc. Sep 2, 2025 1 $0 4 Sep 2, 2025 Director
MGX Metagenomi, Inc. Aug 11, 2025 0 $0 3 Aug 15, 2025 Director
KALV KalVista Pharmaceuticals, Inc. Nov 23, 2024 1 $0 4 Nov 26, 2024 Director
KALV KalVista Pharmaceuticals, Inc. Nov 23, 2024 0 $0 3 Nov 26, 2024 Director
DBTX Decibel Therapeutics, Inc. Sep 25, 2023 4 $0 4 Sep 25, 2023 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. Mar 16, 2023 2 $0 4 Mar 17, 2023 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. Feb 25, 2022 1 $0 4 Feb 28, 2022 President and Chief Executive Officer, Director
DBTX Decibel Therapeutics, Inc. Sep 15, 2021 1 $76.4K 4 Sep 17, 2021 President and Chief Executive, Director